A Project for the transfer of flue vaccine technology, construction and equipment of the biotechnological products production plant in Managua, Republic of Nicaragua. Production capacity: up to 30 million doses of flue vaccine per season. The only biotech plant in Central America, built in accordance with WHO and GMP requirements.

27 april 2014

Signature of the Memorandum between IICVSSP of Russia and INSS of Nicaragua.

12 july 2014

Meeting of the Presidents of Russia and Nicaragua.

Feburary 2015

Constitution of the Latin American Institute of Biotechnology MECHNIKOV, S.A.

23-26 march 2015

Celebration of the First Session of the PAHO Technical Committee on influenza vaccine technology transfer to Nicaragua (CECMED, Cuba).

May- June 2015

Inspection of the IICVSSP influenza vaccine production plant by CECMED, Cuba.

December 2015

Start of construction of the MECHNIKOV Institute Plant.

Februrary 2016

Obtaining GMP Certificate and Sanitary Registry in the name of IICVSSP issued by CECMED, Cuba (ARN of regional reference according to PAHO).

April 2016

Registration of the IICVSSP in the PAHO Revolving Fund as a provider of flue vaccine.

22 october 2016

Construction completion of the MECHNIKOV Institute Plant.

December 2016

Start of commissioning and adjustment, validation and certification works of the MECHNIKOV Institute Plant.

January 2019

Comprehensive GMP certification inspection of the MECHNIKOV Institute Plant by CECMED, Cuba and Pharmacy Directorate, Nicaragua.

March 2019

Obtaining the GMP Certificate issued by CECMED, Cuba in favor of the MECHNIKOV Institute Plant.

April 2019

Start of production, filling of the first commercial batches of the influenza vaccine.